3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
2352
Neoplasms
1707
Prostatic Neoplasms
1197
Lung Neoplasms
923
Colorectal Neoplasms
882
Carcinoma, Non-Small-Cell Lung
867
Leukemia, Myeloid, Acute
593
Pancreatic Neoplasms
577
Multiple Myeloma
549
Carcinoma, Hepatocellular
516
Brain Neoplasms
513
Neoplasm Metastasis
459
Head and Neck Neoplasms
454
Melanoma
414
Ovarian Neoplasms
413
Glioblastoma
402
Precursor Cell Lymphoblastic Leukemia-Lymphoma
400
Stomach Neoplasms
375
Uterine Cervical Neoplasms
365
Squamous Cell Carcinoma of Head and Neck
361
Rectal Neoplasms
341
Recurrence
336
Sarcoma
325
Hematologic Neoplasms
323
Colonic Neoplasms
323
Lymphoma
319
Triple Negative Breast Neoplasms
291
Carcinoma, Renal Cell
283
Urinary Bladder Neoplasms
281
Glioma
278
Interventions
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Embolism and Thrombosis
×
1 year
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled